His research focus is pharmaceutical health services research, specifically examining how pharmacy benefit structures within government and private health insurance affect drug utilization and patient outcomes. He is leading a multi-state effort to explore how Medicaid policies involving opioids affect adverse events related to opioid misuse and abuse. He is also principal investigator on a project to develop and pilot a prescription drug monitoring program toolkit to help community pharmacists improve the safety of opioid use.